BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9068470)

  • 1. Corticosteroid-associated complications in elderly Crohn's disease patients.
    Akerkar GA; Peppercorn MA; Hamel MB; Parker RA
    Am J Gastroenterol; 1997 Mar; 92(3):461-4. PubMed ID: 9068470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
    Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ
    Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry.
    Lichtenstein GR; Feagan BG; Cohen RD; Salzberg BA; Diamond RH; Chen DM; Pritchard ML; Sandborn WJ
    Clin Gastroenterol Hepatol; 2006 May; 4(5):621-30. PubMed ID: 16678077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of Crohn's disease following corticosteroid-induced remission.
    Papi C; Festa V; Leandro G; Moretti A; Tanga M; Koch M; Capurso L
    Am J Gastroenterol; 2007 Apr; 102(4):814-9. PubMed ID: 17222316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients.
    Alves A; Panis Y; Bouhnik Y; Pocard M; Vicaut E; Valleur P
    Dis Colon Rectum; 2007 Mar; 50(3):331-6. PubMed ID: 17252288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations.
    Barreiro-de Acosta M; Domínguez-Muñoz JE; Núñez-Pardo de Vera MC; Lozano-León A; Lorenzo A; Peña S
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):73-8. PubMed ID: 17206080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study.
    Nørgård B; Pedersen L; Christensen LA; Sørensen HT
    Am J Gastroenterol; 2007 Jul; 102(7):1406-13. PubMed ID: 17437503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of early surgery for Crohn's disease: implications for early treatment strategies.
    Sands BE; Arsenault JE; Rosen MJ; Alsahli M; Bailen L; Banks P; Bensen S; Bousvaros A; Cave D; Cooley JS; Cooper HL; Edwards ST; Farrell RJ; Griffin MJ; Hay DW; John A; Lidofsky S; Olans LB; Peppercorn MA; Rothstein RI; Roy MA; Saletta MJ; Shah SA; Warner AS; Wolf JL; Vecchio J; Winter HS; Zawacki JK
    Am J Gastroenterol; 2003 Dec; 98(12):2712-8. PubMed ID: 14687822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease.
    Gelbmann CM; Rogler G; Gross V; Gierend M; Bregenzer N; Andus T; Schölmerich J
    Am J Gastroenterol; 2002 Jun; 97(6):1438-45. PubMed ID: 12094862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease.
    Lichtenstein GR; Olson A; Travers S; Diamond RH; Chen DM; Pritchard ML; Feagan BG; Cohen RD; Salzberg BA; Hanauer SB; Sandborn WJ
    Am J Gastroenterol; 2006 May; 101(5):1030-8. PubMed ID: 16606351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease.
    Picco MF; Zubiaurre I; Adluni M; Cangemi JR; Shelton D
    Am J Gastroenterol; 2009 Nov; 104(11):2754-9. PubMed ID: 19584832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerotic risk factors and renal function in the elderly: the role of hyperfibrinogenaemia and smoking. Results from the Italian Longitudinal Study on Ageing (ILSA).
    Baggio B; Budakovic A; Perissinotto E; Maggi S; Cantaro S; Enzi G; Grigoletto F;
    Nephrol Dial Transplant; 2005 Jan; 20(1):114-23. PubMed ID: 15572387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
    von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M
    Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study.
    Pearte CA; Furberg CD; O'Meara ES; Psaty BM; Kuller L; Powe NR; Manolio T
    Circulation; 2006 May; 113(18):2177-85. PubMed ID: 16651468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
    Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G
    Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of complications during rehabilitation.
    Siegler EL; Stineman MG; Maislin G
    Arch Intern Med; 1994 Oct; 154(19):2185-90. PubMed ID: 7944839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
    Kim PS; Zlatanic J; Korelitz BI; Gleim GW
    Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease.
    Thia KT; Sandborn WJ; Lewis JD; Loftus EV; Feagan BG; Steinhart AH; Hanauer SB; Persson T; Sands BE
    Am J Gastroenterol; 2008 Dec; 103(12):3123-31. PubMed ID: 18786111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-specific risks for pediatric onset among patients with Crohn's disease.
    Montgomery SM; Wakefield AJ; Ekbom A
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):303-9. PubMed ID: 15017672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.